Human γS-Crystallin-Copper Binding Helps Buffer against Aggregation Caused by Oxidative Damage.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
30 06 2020
Historique:
pubmed: 9 6 2020
medline: 25 2 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Divalent metal cations can play a role in protein aggregation diseases, including cataract. Here we compare the aggregation of human γS-crystallin, a key structural protein of the eye lens, via mutagenesis, ultraviolet light damage, and the addition of metal ions. All three aggregation pathways result in globular, amorphous-looking structures that do not elongate into fibers. We also investigate the molecular mechanism underlying copper(II)-induced aggregation. This work was motivated by the observation that zinc(II)-induced aggregation of γS-crystallin is driven by intermolecular bridging of solvent-accessible cysteine residues, while in contrast, copper(II)-induced aggregation of this protein is exacerbated by the removal of solvent-accessible cysteines via mutation. Here we find that copper(II)-induced aggregation results from a complex mechanism involving multiple interactions with the protein. The initial protein-metal interactions result in the reduction of Cu(II) to Cu(I) with concomitant oxidation of γS-crystallin. In addition to the intermolecular disulfides that represent a starting point for aggregation, intramolecular disulfides also occur in the cysteine loop, a region of the N-terminal domain that was previously found to mediate the early stages of cataract formation. This previously unobserved ability of γS-crystallin to transfer disulfides intramolecularly suggests that it may serve as an oxidation sink for the lens after glutathione levels have become depleted during aging. γS-Crystallin thus serves as the last line of defense against oxidation in the eye lens, a result that underscores the chemical functionality of this protein, which is generally considered to play a purely structural role.

Identifiants

pubmed: 32510933
doi: 10.1021/acs.biochem.0c00293
pmc: PMC7732359
mid: NIHMS1621658
doi:

Substances chimiques

Disulfides 0
gamma-Crystallins 0
CRYGS protein, human 148467-57-6
Copper 789U1901C5
Cysteine K848JZ4886

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2371-2385

Subventions

Organisme : NEI NIH HHS
ID : R01 EY021514
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY025328
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Références

J Inorg Biochem. 2001 Mar;84(1-2):77-88
pubmed: 11330484
J Biol Inorg Chem. 2018 Oct;23(7):1105-1118
pubmed: 30167892
Protein Sci. 2016 Jun;25(6):1115-28
pubmed: 26991007
Exp Eye Res. 1998 Jul;67(1):21-30
pubmed: 9702175
Biomol NMR Assign. 2012 Apr;6(1):63-7
pubmed: 21735120
Biochemistry. 2011 Apr 26;50(16):3279-81
pubmed: 21417258
Biochemistry. 2009 Aug 4;48(30):7334-41
pubmed: 19558189
Biochemistry. 2005 May 10;44(18):6776-87
pubmed: 15865423
Optom Vis Sci. 1995 Dec;72(12):899-901
pubmed: 8749337
Br J Ophthalmol. 1992 Nov;76(11):668-9
pubmed: 1477042
Biopolymers. 1999 May;49(6):451-8
pubmed: 10193192
J Biol Chem. 2011 Apr 1;286(13):11047-55
pubmed: 21258123
Biochemistry. 2019 Oct 8;58(40):4112-4124
pubmed: 31490062
Biochem Biophys Res Commun. 2015 Oct 30;466(4):622-8
pubmed: 26385181
J Biol Chem. 1990 Aug 5;265(22):13268-75
pubmed: 2142945
Exp Eye Res. 1997 Jul;65(1):99-104
pubmed: 9237870
PLoS One. 2016 Jan 21;11(1):e0147576
pubmed: 26794210
Biophys Chem. 2001 Jan 31;89(1):65-76
pubmed: 11246746
Mol Cell. 2016 Feb 4;61(3):341-351
pubmed: 26849192
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977 Sep 30;204(1):67-72
pubmed: 303483
Prog Biophys Mol Biol. 2014 Jul;115(1):21-31
pubmed: 24613629
Biochim Biophys Acta. 2008 Dec;1784(12):1959-64
pubmed: 18761110
J Biol Chem. 2016 Sep 2;291(36):19172-83
pubmed: 27417136
Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3237-44
pubmed: 10586948
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2397-2405
pubmed: 28444328
J Biol Chem. 2018 Nov 16;293(46):17997-18009
pubmed: 30242128
Eye (Lond). 1999 Jun;13 ( Pt 3b):403-8
pubmed: 10627817
Trends Neurosci. 2003 Apr;26(4):207-14
pubmed: 12689772
PLoS One. 2012;7(12):e51401
pubmed: 23284690
Protein Pept Lett. 2010 Sep;17(9):1155-62
pubmed: 20394579
Oxid Med Cell Longev. 2016;2016:8590578
pubmed: 28116038
J Biol Chem. 2009 Nov 27;284(48):33285-95
pubmed: 19758984
PLoS One. 2017 Feb 16;12(2):e0172182
pubmed: 28207866
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3554-61
pubmed: 22531704
PLoS One. 2012;7(6):e39252
pubmed: 22723976
Biophys J. 2017 Mar 28;112(6):1135-1146
pubmed: 28355541
PLoS One. 2009 Sep 16;4(9):e7052
pubmed: 19756145
J Proteome Res. 2006 Oct;5(10):2554-66
pubmed: 17022627
Photochem Photobiol. 2013 Sep-Oct;89(5):1106-15
pubmed: 23683003
Biochemistry. 2005 Feb 22;44(7):2491-500
pubmed: 15709761
Proc Natl Acad Sci U S A. 1987 Sep;84(17):6088-92
pubmed: 3476929
Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):325-32
pubmed: 26459004
Biochemistry. 2009 May 5;48(17):3708-16
pubmed: 19358562
J Am Chem Soc. 2012 Feb 8;134(5):2500-3
pubmed: 22280304
Nat Struct Biol. 2000 Sep;7(9):766-71
pubmed: 10966647
J Neurochem. 2010 May;113(3):704-14
pubmed: 20141569
Nat Chem Biol. 2006 Jul;2(7):367-8
pubmed: 16732294
Curr Top Med Chem. 2001 Dec;1(6):507-17
pubmed: 11895127
Free Radic Biol Med. 2004 Nov 1;37(9):1479-89
pubmed: 15454288
Exp Eye Res. 1999 Jun;68(6):773-84
pubmed: 10375441
J Proteome Res. 2007 Oct;6(10):3935-43
pubmed: 17824632
Mol Vis. 2004 Jul 19;10:476-89
pubmed: 15303090
Science. 2003 Sep 5;301(5638):1383-7
pubmed: 12958362
Biochemistry. 2009 Dec 15;48(49):11640-54
pubmed: 19883117
J Phys Condens Matter. 2018 Oct 31;30(43):435101
pubmed: 30280702
Nat Commun. 2017 May 05;8:15137
pubmed: 28474685
Peptides. 2007 Nov;28(11):2229-34
pubmed: 17919778
J Biol Chem. 2004 Dec 17;279(51):53584-92
pubmed: 15465825
Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):333-43
pubmed: 26116913
Biochemistry. 1982 Jan 5;21(1):117-25
pubmed: 7037051
J Chem Inf Model. 2016 Dec 27;56(12):2287-2291
pubmed: 27976886
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3608-19
pubmed: 15452068
Photochem Photobiol. 1997 Mar;65(3):522-9
pubmed: 9077138
Biochem Biophys Res Commun. 2014 Jan 3;443(1):110-4
pubmed: 24287181
Mol Vis. 2006 Jun 21;12:704-11
pubmed: 16807530
J Biol Chem. 1991 Apr 5;266(10):6456-61
pubmed: 2007594
Curr Opin Chem Biol. 2000 Apr;4(2):140-7
pubmed: 10742187
J Am Chem Soc. 2019 Sep 11;141(36):14329-14339
pubmed: 31433629
Protein Sci. 2005 Mar;14(3):569-81
pubmed: 15722442
Exp Eye Res. 1981 Dec;33(6):615-20
pubmed: 7318958
ACS Chem Biol. 2016 Jan 15;11(1):263-72
pubmed: 26579725
Biochemistry. 2008 Oct 7;47(40):10705-21
pubmed: 18795792
Biol Trace Elem Res. 2005 Winter;108(1-3):33-41
pubmed: 16327057
Nat Struct Mol Biol. 2019 Dec;26(12):1141-1150
pubmed: 31792453
Exp Eye Res. 1998 Nov;67(5):587-95
pubmed: 9878221
Br J Ophthalmol. 1998 Feb;82(2):186-8
pubmed: 9613387
Exp Eye Res. 1998 Sep;67(3):301-12
pubmed: 9778411
Acc Chem Res. 2014 Aug 19;47(8):2252-9
pubmed: 24871565
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5212-7
pubmed: 17122105
Biochemistry. 2019 Nov 12;58(45):4505-4518
pubmed: 31647219
Biochemistry. 2006 Sep 26;45(38):11552-63
pubmed: 16981715
Protein Sci. 2004 Aug;13(8):2223-35
pubmed: 15273315
Biochemistry. 2018 Aug 21;57(33):4959-4962
pubmed: 30064223
J Biol Chem. 2013 Jan 4;288(1):99-109
pubmed: 23124202
Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3595-3604
pubmed: 30251679
Exp Eye Res. 1998 Jul;67(1):31-43
pubmed: 9702176
Mol Vis. 2013 Jun 05;19:1231-7
pubmed: 23761725
Prog Biophys Mol Biol. 2004 Nov;86(3):407-85
pubmed: 15302206
Metallomics. 2014 Apr;6(4):793-808
pubmed: 24522867
J Gen Physiol. 2016 Feb;147(2):189-200
pubmed: 26755772
Anal Bioanal Chem. 2014 Apr;406(9-10):2343-8
pubmed: 24500754
J Mol Biol. 2019 Feb 1;431(3):483-497
pubmed: 30552875
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2007-12
pubmed: 20133845
J Ocul Pharmacol Ther. 2000 Apr;16(2):121-35
pubmed: 10803423
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Prog Biophys Mol Biol. 2014 Jul;115(1):32-41
pubmed: 24835736

Auteurs

Kyle W Roskamp (KW)

Department of Chemistry, University of California, Irvine, California 92697-2025, United States.

Sana Azim (S)

Max Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.

Günther Kassier (G)

Max Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.

Brenna Norton-Baker (B)

Department of Chemistry, University of California, Irvine, California 92697-2025, United States.
Max Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.

Marc A Sprague-Piercy (MA)

Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900, United States.

R J Dwyane Miller (RJD)

Max Planck Institute for the Structure and Dynamics of Matter, Center for Free Electron Laser Science, Luruper Chaussee 149, Hamburg 22761, Germany.
Departments of Chemistry and Physics, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada.

Rachel W Martin (RW)

Department of Chemistry, University of California, Irvine, California 92697-2025, United States.
Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH